Eligibility for anti-fibrotic therapy of patients in British Thoracic Society (BTS) UK IPF Registry varies according to the reference values used to calculate FVC

被引：1

作者：

Molyneaux, Phil ^{[1
]}

Loughenbury, Maria ^{[2
]}

Welham, Sally ^{[2
]}

Hutchinson, John ^{[3
]}

Adamali, Huzaifa ^{[4
]}

Fahim, Ahmed ^{[5
]}

Agnew, Sarah ^{[6
]}

Funston, Wendy ^{[7
]}

Haney, Sarah ^{[8
]}

Ho, Ling-Pei ^{[9
]}

Richardson, Jack ^{[10
]}

Almond, Howard ^{[11
]}

Jones, Steve ^{[11
]}

Nicol, Lisa ^{[12
]}

Spinks, Katherine ^{[13
]}

Wilson, Andrew ^{[14
]}

Spencer, Lisa ^{[6
]}

机构：

[1] Imperial Coll London, London, England

[2] British Thorac Soc, London, England

[3] Kings Mill Hosp, Notingham, England

[4] Southmead Hosp, Bristol, Avon, England

[5] New Cross Hosp, Wolverhampton, England

[6] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England

[7] Queen Elizabeth Hosp, Gateshead, England

[8] Wansbeck Gen Hosp, Ashington, England

[9] Churchill Hosp, Oxford, England

[10] Sarcoidosis UK, London, England

[11] Act Pulm Fibrosis, Bury St Edmunds, Suffolk, England

[12] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

[13] Lymington New Forest Hosp, Lymington, England

[14] Norwich Med Sch, Norwich, Norfolk, England

来源：

关键词：

Idiopathic pulmonary fibrosis;

D O I：

10.1183/13993003.congress-2020.1798

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

1798

引用

页数：2